Nextage will design an innovative platform for patients with diabetes

Posted on Apr 30, 2015 in News, Research

Nextage leads one of the 9 consortia awarded with DECIPHER PCP Phase I tender. Throughout Phase I we will produce the final design of DECIPHER platform competing for Phase II (prototype development). Our consortium scored a 2nd place (overall result), with the highest technical score among all competitors. About the consortium The consortium is a partnership between Nextage and  Camelot Biomedical Systems, an hi-tech company based in Genoa....

Read More